Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Board of Directors of Pharmsintez proposed an additional share issue

11/20/23 LIFE

Magnit will expands the geography of sales of ready-to-eat food in stores at home

11/20/23 MGNT

Astra reported for 9 months of 2023 by IFRS

11/20/23 ASTR

Sovcomflot reported for 9 months of 2023 by IFRS

11/20/23 FLOT

Institutional investor acquired 4.2% of Softline

11/20/23 SOFL

Bulgaria bans Russian oil supplies to Lukoil refinery

11/20/23 LKOH

CarMoney reported 9 months of 2023 by IFRS

11/20/23 CARM

UAC patents supersonic tactical aircraft

11/20/23 UNAC

QIWI reported for 9 months of 2023

11/17/23 QIWI

Chechia wants to continue importing NLMK products

11/17/23 NLMK